| Статус: | Recruiting |
| Фаза: | Phase 3 |
| Начало: | 23 мая 2024 г. |
| Окончание: | 1 декабря 2028 г. |
| Описание: | Objective: to evaluate the efficacy and safety of the non-immunogenic recombinant staphylokinase with its single bolus administration in comparison with placebo in normotensive patients with intermediate high-risk pulmonary embolism (PE) |
| смотреть на ClinicalTrials.gov |
| Статус: | Completed |
| Фаза: | не указано |
| Начало: | 29 февраля 2024 г. |
| Окончание: | 24 сентября 2024 г. |
| Описание: | Patients with diabetes mellitus are characterized by "hyperreactive" platelets and a reduced response to ASA compared to individuals without diabetes. ASA that is absorbed in the intestine is slower to enter the bloodstream and become therapeutic concentrations compared to ASA that is absorbed in the stomach. It seems rational to test the hypothesis that the use of buffered ASA may be more effective in patients with diabetes and chronic coronary syndrome (CCS). |
| смотреть на ClinicalTrials.gov |